Publikationsverzeichnis. Akademische Schriften

Transkript

1 Publikationsverzeichnis Akademische Schriften Dissertation S. Hoffmann Zeitlicher Verlauf von Mitoserate und histologischen Veränderungen nach Hautexpansion Dissertationsschrift zur Erlangung des medizinisches Doktorgrades der Medizinischen Universität Lübeck (1994) Habilitationsschrift S. Hoffmann Regulation der Tumorangiogenese und Evaluation antiangiogen/antiproliferativer Therapieansätze beim Schilddrüsenkarzinom Habilitationsschrift zur Erlangung der Venia legendi für das Fach Chirurgie des Fachbereichs Humanmedizin der Philipps Universität Marburg (2008) Originalarbeiten Erstautor/Seniorautor: Hoffmann S, Koller M, Plaul U, Stinner B, Gerdes B, Lorenz W, Rothmund M. Nasogastric tube versus percutaneous gastrostomy for gastric decompression in abdominal surgery: A prospective, randomized trial comparing patients tube-related inconvenience Langenbecks Arch Surg 2001 Nov;386(6):402-9 Hoffmann S, Hofbauer LC, Scharrenbach V, Wunderlich A, Hassan I, Lingelbach S, Zielke A. Thyrotropin (TSH)-Induced Production of Vascular Endothelial Growth Factor in Thyroid Cancer Cells in Vitro: Evaluation of TSH Signal Transduction and of Angiogenesis-Stimulating Growth Factors J Clin Endocrinol Metab : Hoffmann S, Maschuw K, Hassan I, Reckzeh B, Wunderlich A, Lingelbach S, Zielke A. Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines. Thyroid Sep;15(9): Hoffmann S, Wunderlich A, Celik I, Maschuw K, Hassan I, Lingelbach S, Zielke A Paneling human thyroid cancer cell lines for candidate proteins for targeted antiangiogenic therapy. J Cell Biochem Jul 1;98(4): Hoffmann S, Gläser S, Wunderlich A, Maschuw K, Burchert A, Celik I, Rothmund M, Zielke A Targeting the EGF/VEGF-R system by thyrosine-kinase inhibitors, a new option of antiproliferative/antiangiogenic therapy in thyroid cancer? Langenbecks Arch Surg Nov;391(6):589-96

2 Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells Mol Cell Endocrinol Jan 29;264(1-2):74-81 Hoffmann S, Maschuw K, Hassan I, Ramaswamy A, Wunderlich A, Lingelbach S, Zielke A Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells Endocrine Aug;30(1): Hoffmann S, Burchert A, Wunderlich A, Lingelbach S, Hofbauer LC, Maschuw K, Ramaswamy A, Celik I, Zielke Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines Endocrine Apr;31(2): Hoffmann S, Wunderlich A, Lingelbach S, Musholt PB, Musholt TJ, von Wasielewski R, Zielke A. Expression and secretion of endostatin in thyroid cancer. Ann Surg Oncol Dec;15(12): Wunderlich A, Fischer M, Schlosshauer T, Ramaswamy A, Greene BH, Brendel C, Doll D, Bartsch D, Hoffmann S. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer. Cancer Sci Apr;102(4):762-8 Wunderlich A, Arndt T, Fischer M, Roth S, Ramaswamy A, Greene BH, Brendel C, Hinterseher U, Bartsch DK, Hoffmann S.Targeting the proteasome as a promising therapeutic strategy in thyroid cancer. J Surg Oncol Mar 15;105(4): Wunderlich A, Roth S, Ramaswamy A, Greene BH, Brendel C, Hinterseher U, Bartsch DK, Hoffmann S. Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer Endocrine Apr Dec;42(3): Doll D, Matevossian E, Hoenemann C, Hoffmann S. Incision and drainage preceding definite surgery achieves lower 20-year long-term recurrence rate in 583 primary pilonidal sinus surgery patients. J Dtsch Dermatol Ges Jan;11(1):60-4. Wunderlich A, Khoruzhyk M, Roth S, Ramaswamy A, Greene BH, Doll D, Bartsch DK, Hoffmann S. Pretherapeutic drug evaluation by tumor xenografting in anaplastic thyroid cancer. J Surg Res Jun 29. Hinterseher U, Wunderlich A, Roth S, Ramaswamy A, Bartsch DK, Hauptmann S, Greene BH, Fendrich V, Hoffmann S. Expression of hedgehog signalling pathway in anaplastic thyroid cancer. Endocrine Jul 17. Coautor:

3 Siegert R, Weerda H, Hoffmann S, Mohadjer C. Clinical and experimental evaluation of intermittent intraoperative short-term expansion. Plast Reconstr Surg Aug;92(2): Zielke A, Hoffmann S, Plaul U, Duh QY, Clark OH, Rothmund M. Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion. Exp Clin Endocrinol Diabetes 1999;107(6):361-9 Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-vegf antibodies in experimental tumors. Surgery Dec;132(6): Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Exp Clin Endocrinol Diabetes Nov;110(8): Koller M, Hoffmann S, Rothmund M, Lorenz W, Plaul U. Checking for interviewer bias in outcome assessment: a method for strengthening the design of prospective, randomised trials in surgery Langenbecks Arch Surg Apr;389(2):92-6 Sitter H, Hoffmann S, Hassan I, Zielke A. Diagnostic score in appendicitis. Validation of a diagnostic score (Eskelinen score) in patients in whom acute appendicitis is suspected. Langenbecks Arch Surg Jun;389(3):213-8 Hassan I, Wunderlich A, Burchert A, Hoffmann S, Zielke A. Antisense p53 oligonucleotides inhibit proliferation and induce chemosensitivity in follicular thyroid cancer cells. Anticancer Res Mar-Apr;26(2A): Hassan I, Wunderlich A, Slater E, Hoffmann S, Celik I, Zielke A. Antisense p53 Decreases Production of VEGF in Follicular Thyroid Cancer Cells. Endocrine Jun;29(3): Hassan I, Koller M, Kluge C, Hoffmann S, Zielke A, Rothmund M. Supervised surgical trainees perform thyroid surgery for Graves' disease safely. Langenbecks Arch Surg Nov;391(6): Hassan I, Danila R, Aljabri H, Hoffmann S, Wunderlich A, Karakas E, Zielke A Is rapid preparation for thyroidectomy in severe Graves' disease beneficial? The relationship between clinical and immunohistochemical aspects. Endocrine Apr;33(2): Epub 2008 May 21.

4 Karakas E, Osei-Agyemang T, Schlosser K, Hoffmann S, Zielke A, Rothmund M, Hassan I. The impact of parathyroid gland autotransplantation during bilateral thyroid surgery for Graves' disease on postoperative hypocalcaemia. Endocr Regul Jun;42(2-3): Westhoff CC, Hoffmann S, Barth PJ.Clear Cell Follicular Adenoma of the Thyroid - A Challenge in Intra-operative Diagnostics. Exp Clin Endocrinol Diabetes Jan;118(1): Epub 2009 Feb 20. publizierte Abstracts Erstautor: Hoffmann S, Koller M, Stinner B, Gerdes B, Rothmund M Nasogastrale Sonde versus perkutane Gastrostomie-Messung der Beschwerden von Patienten im Rahmen einer prospektiven, randomisierten Studie Chirurgische Forschungstage1999, Marburg Langenbecks Arch Surg 1999; Suppl 6:127 Hoffmann S, Koller M, Stinner B, Gerdes B, Rothmund M Nasogastric tube versus percutaneous gastrostomy for gastric decompression in abdominal surgery: A prospective, randomized trial comparing patients tube-related inconvenience World Congress of Surgery, Wien 1999 World J Surg (11): Hoffmann S, Zielke A, Maschuw W, Reckzeh B, Hassan I, Rothmund M. Differential pattern of integrin receptor expression and adhesion of differentiated thyroid cancer cell lines in vitro: a systematic investigation. 45. Symposium der Deutschen Gesellschaft für Endokrinologie März 2001, Magdeburg Exp Clin Endocrinol Diabetes 2001; Suppl1 :3 Hoffmann S, Zielke A, Lingelbach S, Wunderlich A, Hassan I, Rothmund M. Einfluss der Redifferenzierungstherapie mit Retinoiden auf Proliferation und VEGF Produktion der malignen Schilddrüsentumorzellinien in vitro. 20. Arbeitstagung der Chirugischen Arbeitsgemeinschaft Endokrine Chirurgie (CAEK) November 2001, Bern, Schweiz Langenbecks Arch Surg; Suppl 2:87 Hoffmann S, Zielke A, Maschuw W, Reckzeh B, Hassan I, Rothmund M. Integrin receptor expression and adhesion characteristics of differentiated thyroid cancer cell lines in vitro: a systematic investigation. Annual Meeting of the European Thyroid Asociation

5 August 2001, Warschau, Polen J Endocrinol Invest 2001; Suppl 6:117 Hoffmann S., Scharrenbach V., Hofbauer L., Wunderlich A., Hassan Y., Rothmund M., Zielke A Identification of angiogenesis-stimulating growth factors and analysis of signal transduction 23. Meeting of the European Thyroid Association (ETA) November 2003, Edinburgh, Schottland J Endocrinol Invest 2003; Suppl P96: 82 Hoffmann S, Hassan I, Wunderlich A, Lingelbach S, Zielke A Antiproliferative Wirkung neutralisierender anti-vegf Antikörper beim experimentellen Schilddrüsenkarzinom. 22. Jahrestreffen der CAEK Dezember 2003, Frankfurt Langenbecks Arch Surg 2003; Suppl 1:43 Hoffmann S, Hassan I, Wunderlich A, Lingelbach S, Zielke A Die Transfektion follikulärer Schilddrüsenkarzinomzellen mit Thyreotropinrezeptor cdna verändert den malignen Phänotyp in vitro und in vivo. 22. Jahrestreffen der CAEK Dezember 2003, Frankfurt Langenbecks Arch Surg 2003; Suppl 1:55 Hoffmann S, Hofbauer LC, Wunderlich A, Celik I, Rothmund M, Zielke A EGF-stimulated VEGF production in thyroid cancer cells in vitro 24. Meeting of the European Thyroid Association (ETA) September 2004, Instanbul, Türkei J Endocrinol Invest 2004; Suppl P43: 32 Hoffmann S, Hofbauer LC, Wunderlich A, Celik I, Rothmund M, Zielke A The ERF/EGFR system as a possible target for anti tumor therapy in thyroid cancer Jahrestagung der Deutschen Gesellschaft für Endokrinologie März 2005, Münster Exp Clin Endocrinol Diabetes 2005; Suppl2 :14 Hoffmann S, Wunderlich A, Maschuw K, Burchert A, Celik I, Zielke A The EGF/EGF- R system as a possible target of antiproliferative/antiangiogenic therapy in thyroid cancer 24. Jahrestreffen der CAEK November 2005, Hamburg Langenbecks Arch Surg 2005; Suppl 3:13

6 Hoffmann S, Burchert A, Wunderlich A, Maschuw K, Celik I, Zielke A Hemmung des EGF-R/VEGF-R durch einen dualen Thyrosinkinaseinhibitor (AEE788), ein neuer Therapieansatz beim Schilddrüsenkarzinom? 123. Kongress der Deutschen Gesellschaft für Chirurgie Mai 2006, Berlin Langenbecks Arch Surg Forumsband 2006; 45-7 Hoffmann S, Gläser S, Wunderlich A, Maschuw K, Burchert A, Celik I, Rothmund M, Zielke A Targeting the EGF/VEGF-R system by thyrosine-kinase inhibitors, a new option of antiproliferative/antiangiogenic therapy in thyroid cancer? 2. Biennal meeting of the ESES Mai 2006, Krakow, Poland Langenbecks Arch Surg 2006; Suppl 2:55 Zimmer S., Teichler S., Wunderlich A., Lingelbach S., Neubauer A., Rothmund M., Hoffmann S. In vitro evaluation of proteasome inhibiton by Bortezomib as a new option of antiproliferative therapy in anaplastic thyroid cancer Langenbecks Arch Surg Suppl 2007, 392: Hoffmann S, Zimmer S., Teichler S., Wunderlich A., Lingelbach S., Neubauer A., Rothmund M. Combination of a proteasome inhibitor and a tyrosine kinase inhibitor is an effective new anti-proliferative strategy in anaplastic thyroid cancer cells 3. Biennal meeting of the ESES, Barcelona 2008 Langenbecks Arch Surg Suppl 2008 Hoffmann S., Josephs D., Wunderlich A., Burchert A., Zimmer S., Rothmund M., Zielke A Combined targeting of the EGF/VEGF-R system leads to reduced tumor proliferation and tumor angiogenesis of anaplastic thyroid cancer in vivo 3. Biennal meeting of the ESES, Barcelona 2008 Langenbecks Arch Surg Suppl 2008 Hoffmann S., Schloßhauer T., Burchert A., Ramaswamy A., Bartsch D., Wunderlich A. Establishing an in vivo tumor transplant model allowing prospective evaluation of individualized anti-proliferative strategies in anaplastic thyroid cancer 4. Biennal meeting of the ESES, Vienna 2010 Langenbecks Arch Surg 2010; Suppl 2:21 Hoffmann S., Fischer M., Arndt T., Hinterseher U., Brendel C., Bartsch D., Wunderlich A. Effects of combined proteasome and aurora kinase inhibiton on anaplastic thyroid cancer in vitro and in vivo Langenbecks Arch Surg 2011; Suppl Hinterseher U., Riera-Knorrenschild J., Ramaswamy A., Bartsch D., Wunderlich A., Hoffmann S. Management of primary poorly differentiated angiosarcoma of the thyroid Langenbecks Arch Surg 2012; Suppl Hoffmann S, Schloßhauer T, Arndt T, Hinterseher U, Burchert A, Ramaswamy A, Bartsch D, Wunderlich A Tailored antitumor therapy by in vivo evaluation of

7 individualized anti-proliferative strategies in a tumor transplant model of anaplastic thyroid cancer ExpClinEndocrinolDiabetes Suppl 2012 Coautor: Hassan I, Zielke A, Hoffmann S, Plaul U, Nies C. Operative Therapie der Autoimmunthyreopathie vom Typ des M. Basedow als Ausbildungseingriff? -Ein Plädoyer für die "Chirurgische Schule". Acta Chir Austriaca 31, Suppl 154, A229, 1999 A. Zielke, M. Middeke, S. Hofmann, Hassan I, M. Rothmund. Evidence for VEGF driven angiogenesis in rat PC12 pheochromocytoma and antiangiogenetic properties of neutralizing VEGF antibodies. November 2000, Düsseldorf Langenbecks Arch Surg 2000; Suppl3;427:18 Zielke A, Middeke M, Hoffmann S, Hassan I, Hofbauer LC, Barth P, Rothmund M Die Angiogenese in der Phäochromozytomzelllinie PC12 ist VEGF vermittelt und durch Nervenwachstumsfaktor NGF reguliert 45. Symposium der Deutschen Gesellschaft für Endokrinologie März 2001, Magdeburg Exp Clin Endocrinol Diabetes 2001; Suppl1 :35 Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY VEGF-mediated angiogenesis in human pheochromocytomas is associated with malignant phenotype and is inhibited by neutralizing anti-vegf antibodies in xenografts of PC12 pheochromocytomas to nude mice 23rd Meeting of the American Association of Endocrine Surgeons April 2002, Banff, Canada Surgery 2002; Suppl 3:67 Hassan I, Hoffmann S, Wunderlich A, Zielke A Oligodesoxyribonukleotid Phosphothioate (ODN) gegen die Synthese von mtp53 vermindern Proliferation, VEGF-Sekretion und steigern die Chemosensibilität in der follikulären Schilddrüsenkarzinom-Zelllinie FTC Jahrestagung der CEAK, November 2002, Potsdam Langenbecks Arch Surg 2003; Suppl 1:43 Hassan I, Hoffmann S, Wunderlich A, Zielke A Oligodesoxyribonucleotide phosphothioates (ODN) complementary tp mtp53 nucleotide sequences inhibit proliferation, VEGF secretion and induce chemosensitivity in follicular cell line FTC Annual Meeting of the American Thyroid Association Oktober.2002, Los Angeles, USA

8 Thyroid 2002; Suppl4:75 Hassan I, Koller M, Kluge C, Hoffmann S, Rothmund M, Zielke A. Postoperative morbidity after bilateral Thyroid surgery for Grave`s Disease: 15 years experience in a specialized center. Langenbecks Arch. Surg 390, 6:562 Hassan I, Danila R, Aljabri H, Hoffmann S, Rothmund M, Zielke A. Rapid preparation correlates with higher morbidity after thyroid resection and increased VEGF expression in Graves' hyperthyroidism: a clinical pathological study. 2th Biennial Congress of the ESES. Langenbecks Arch. Surg 2005; Suppl p26: 261 Hassan I, Celik I, Koller M, Barth P, Hoffmann S, Rothmund M, Zielke A. The fine needle aspiration cytology in endemic goitre region - a diagnostic roulette. 2th Biennial Congress of the ESES. Langenbecks Arch. Surg 2005; Suppl p27: 262 Hassan I, Aljabri H, Hoffmann S, Wunderlich A, Rothmund M, Zielke A. Clinical and angiogenic characteristics of rapid preoperative preparation of severe Graves hyperthyroidism for thyroidectomy: is there a benefical effect? Langenbecks Arch Surg 2006; 391: Hassan I, TM. Behr, Barth P, HH Mueller, Hoffmann S, Rothmund M, Zielke A. Does Fine-Needle Aspiration cytology optimize the surgical management of thyroid disorders in endemic goiter region? Langenbecks Arch Surg 2006;391: Wunderlich A., Lingelbach S., Burchert A., Brendel C., Bartsch D., Hoffmann S. Successful preclinical evaluation of various new anti-proliferative strategies in anaplastic thyroid cancer advocate clinical investigation Langenbecks Arch. Surg 2009; Suppl p18-19 Übersichtsarbeiten Hoffmann S, Zielke A., Rothmund M Schilddrüsenkarzinome Visceralchirurgie 1999; 34: Hoffmann S, Nies C, Rothmund M Chirurgie des Schilddrüsenkarzinoms Therapeutische Umschau 1999; 56: Hoffmann S, Rothmund M Der Effekt von Vitamin C auf die Inzidenz der Algodystrophie

9 AVP 2000; 2:17-18 Buchkapitel Hoffmann S. Undifferenzierte Schilddrüsenkarzinome 2012 S in Rothmund (Hrsg) Praxis der Viszeralchirurgie Endokrine Chirurgie Springer 2012 Hoffmann S. Nichtepitheliale Schilddrüsentumoren und Metastasen 2012 S in Rothmund (Hrsg) Praxis der Viszeralchirurgie Endokrine Chirurgie Springer 2012